Harmony Biosciences Holdings

Harmony Biosciences Holdings reported second-quarter earnings that increased from a year ago. Net income rose to $75.43 million, or $1.28 per share, compared with $39.78 million, or $0.68 per share, in the same period last year. Revenue grew 30.3% to $261.28 million from $200.49 million. The company issued full-year revenue guidance of $1.0 billion to $1.04 billion.

Zacks Equity Research has identified five biotech companies that are expected to beat earnings estimates in their upcoming second-quarter 2026 reports. The stocks are Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed, and Agios Pharmaceuticals, each combining a positive Earnings ESP with a Zacks Rank of 1, 2, or 3. Harmony Biosciences carries an Earnings ESP of +14.14% and a Zacks Rank #1, with a consensus estimate of 97 cents per share, and reports on August 4 before the open. Acadia Pharmaceuticals has an Earnings ESP of +25.00% and a Zacks Rank #2, with a consensus of 6 cents per share, reporting after the close on August 4. Biogen shows an Earnings ESP of +220.79% and a Zacks Rank #3, with a consensus of 94 cents per share, and reports on July 29 before the open. Insmed has an Earnings ESP of +22.32% and a Zacks Rank #3, with a consensus loss of 69 cents per share, reporting on August 6 before the open. Agios Pharmaceuticals has an Earnings ESP of +12.67% and a Zacks Rank #3, with a consensus loss of $1.86 per share, and reports on July 30 before the open.

Harmony Biosciences preannounced record quarterly net product revenue for WAKIX of approximately $261 million for the second quarter of 2026, representing 30% year-over-year growth and 21% sequential growth from the first quarter. The company reaffirmed its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion, citing strong demand and disciplined commercial execution. Harmony also announced that Chief Financial Officer Glenn Reicin has stepped down effective July 16, 2026, and that Stephen Mollichella, Senior Vice President and Controller, has been appointed Interim Principal Financial Officer. The company stated that Mr. Reicin's departure is not due to any disagreement and does not expect the transition to affect its performance. Full second-quarter 2026 financial results will be reported on August 4, 2026.